Newcomer Partner Therapeutics Nabs $60M, Acquires Leukine From Sanofi Post author:Sam Post published:January 31, 2018 Post category:BioPharma Only a week after launch, Partner Therapeutics acquired the global rights to Leukine from Sanofi. Source: BioSpace You Might Also Like Why Even Spinraza Can't Save Biogen's Incoming MS Meltdown October 24, 2017 Polyphor Announces Successful End Of Phase II Meeting With FDA For Murepavadin In Nosocomial Pneumonia May 18, 2017 Paratek Pharma Reports Full Year And Fourth Quarter 2016 Financial Results And Provides Clinical Update March 1, 2017
Polyphor Announces Successful End Of Phase II Meeting With FDA For Murepavadin In Nosocomial Pneumonia May 18, 2017
Paratek Pharma Reports Full Year And Fourth Quarter 2016 Financial Results And Provides Clinical Update March 1, 2017